Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



277 reviews

2,539 Results (Page 2 of 127)
- Relevance
  Sort by

Hepatitis C Treatment - Global Strategic Business Report

 Report
July 2025
208 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028

 Report
May 2022
510 Pages
Global

From

€2656EUR$3,000USD£2,300GBP

Hepatitis Therapeutics - Global Strategic Business Report

 Report
July 2025
298 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
87 Pages
Global

From

€3500EUR$4,235USD£3,137GBP

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4205EUR$4,750USD£3,642GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Drug Delivery Across Blood Brain Barrier Market by Technology, Drug Type, Therapeutic Application, Route of Administration, End User - Global Forecast to 2030

 Report
May 2025
192 Pages
Global

From

€3139EUR$3,545USD£2,718GBP

€3487EUR$3,939USD£3,020GBP

Hepatitis Therapeutics Market by Therapeutic Class, Genotype, Route of Administration, Distribution Channel, Stage of Disease - Global Forecast to 2030

 Report
May 2025
180 Pages
Global

From

€3139EUR$3,545USD£2,718GBP

€3487EUR$3,939USD£3,020GBP

Hepatitis B Therapeutics Market 2024-2028

 Report
June 2024
141 Pages
Global

From

€2213EUR$2,500USD£1,917GBP

Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Leading Players and Sales Forecast

 Report
November 2024
997 Pages
Global

From

€4249EUR$4,799USD£3,680GBP

HIV Clinical Trials - Global Strategic Business Report

 Report
July 2025
379 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

HIV Drugs - Global Strategic Business Report

 Report
July 2025
164 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of Biologics, Route of Administration, Type of Therapy, Key Geographical Regions, Leading Drug Developers and Sales Forecast

 Report
May 2024
240 Pages
Global

From

€4249EUR$4,799USD£3,680GBP

Reyataz (atazanavir; Bristol-Myers Squibb) Drug Overview 2019

 Report
June 2019
18 Pages
Global

€8853EUR$10,000USD£7,668GBP

Skin Cancer Drugs - Global Strategic Business Report

 Report
July 2025
483 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions

 Report
September 2024
375 Pages
Global

From

€4249EUR$4,799USD£3,680GBP

Liraglutide and Semaglutide - Global Strategic Business Report

 Report
July 2025
451 Pages
Global

From

€5179EUR$5,850USD£4,486GBP

Hepatitis Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3975EUR$4,490USD£3,443GBP

Hepatitis Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3975EUR$4,490USD£3,443GBP

Hepatitis B Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
February 2025
181 Pages
Global

From

€3386EUR$3,825USD£2,933GBP

€3984EUR$4,500USD£3,451GBP

Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2789EUR$3,150USD£2,415GBP

2,539 Results (Page 2 of 127)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.